Animals with advanced NASH also showed an increase in hepatic mRNA content of the AnxA1 receptor, Fpr2/3, and presence of Fpr2/3-expressing cells in liver sections (Supporting Fig. 1). Here, FPR2 is linked to metabolic dysfunction-associated steatohepatitis.